Total Payments
$9,999
2024 Payments
$704.49
Companies
29
Transactions
531
Medicare Patients
15,964
Medicare Billing
$791,327
Payment Breakdown by Category
Food & Beverage$9,149 (91.5%)
Travel$786.58 (7.9%)
Other$58.91 (0.6%)
Education$4.64 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,149 | 526 | 91.5% |
| Travel and Lodging | $786.58 | 3 | 7.9% |
| Entertainment | $58.91 | 1 | 0.6% |
| Education | $4.64 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $1,592 | 46 | $0 (2020) |
| Amgen Inc. | $1,569 | 96 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,370 | 83 | $0 (2024) |
| Medtronic, Inc. | $1,023 | 45 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $958.49 | 76 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $610.58 | 31 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $603.55 | 37 | $0 (2024) |
| Abbott Laboratories | $581.45 | 25 | $0 (2019) |
| PFIZER INC. | $516.04 | 38 | $0 (2024) |
| CVRx, Inc. | $183.39 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $704.49 | 39 | Novartis Pharmaceuticals Corporation ($249.02) |
| 2023 | $1,337 | 68 | Amgen Inc. ($309.76) |
| 2022 | $1,316 | 68 | Medtronic, Inc. ($505.77) |
| 2021 | $1,221 | 72 | Novartis Pharmaceuticals Corporation ($402.11) |
| 2020 | $783.60 | 52 | Medtronic Vascular, Inc. ($138.51) |
| 2019 | $969.25 | 69 | Janssen Pharmaceuticals, Inc ($259.13) |
| 2018 | $1,470 | 85 | Abbott Laboratories ($293.79) |
| 2017 | $2,197 | 78 | Medtronic Vascular, Inc. ($1,078) |
All Payment Transactions
531 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Cardiology | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $8.80 | General |
| Category: Cardiology | ||||||
| 10/15/2024 | Medtronic, Inc. | SPIDERFX (Device) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Embolic Protection Devices | ||||||
| 10/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Cardiology | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Cardiology | ||||||
| 09/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Cardiology | ||||||
| 07/26/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/18/2024 | Medtronic, Inc. | VIANCE (Device) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Chronic Total Occlusion (CTO) Devices | ||||||
| 07/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/27/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: VTE | ||||||
| 06/20/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/06/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Cardiology | ||||||
| 05/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Cardiology | ||||||
| 05/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Cardiology | ||||||
| 05/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Cardiology | ||||||
| 04/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,941 | 4,012 | $645,022 | $136,073 |
| 2022 | 25 | 3,932 | 4,844 | $764,379 | $160,450 |
| 2021 | 29 | 4,493 | 6,122 | $1.1M | $241,585 |
| 2020 | 31 | 4,598 | 6,292 | $1.1M | $253,218 |
Total Patients
15,964
Total Services
21,270
Medicare Billing
$791,327
Procedure Codes
115
All Medicare Procedures & Services
115 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 503 | 767 | $182,546 | $63,384 | 34.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 272 | 275 | $84,150 | $13,465 | 16.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 208 | 208 | $81,952 | $11,460 | 14.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 42 | 233 | $29,125 | $10,414 | 35.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 491 | 733 | $73,300 | $7,429 | 10.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 59 | 59 | $21,535 | $6,720 | 31.2% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 64 | 148 | $13,616 | $2,904 | 21.3% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 181 | 181 | $30,247 | $2,800 | 9.3% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 31 | 84 | $5,364 | $2,798 | 52.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 383 | 422 | $21,100 | $2,504 | 11.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 214 | 214 | $35,738 | $2,196 | 6.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 31 | 31 | $9,486 | $1,607 | 16.9% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 59 | 67 | $7,746 | $1,597 | 20.6% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 53 | 128 | $4,480 | $978.74 | 21.8% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Office | 2023 | 63 | 65 | $6,955 | $836.68 | 12.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 15 | 15 | $5,910 | $834.68 | 14.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 86 | 97 | $1,940 | $814.80 | 42.0% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 14 | 14 | $5,012 | $736.95 | 14.7% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 17 | 34 | $4,488 | $653.47 | 14.6% |
| 85610 | Blood test, clotting time | Office | 2023 | 47 | 128 | $4,480 | $537.60 | 12.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 19 | 19 | $2,318 | $520.54 | 22.5% |
| 93270 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | Office | 2023 | 38 | 38 | $7,144 | $239.03 | 3.3% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 11 | 11 | $1,452 | $194.30 | 13.4% |
| 93924 | Ultrasound of leg arteries at rest and after exercise | Facility | 2023 | 11 | 12 | $876.00 | $168.03 | 19.2% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 15 | 15 | $2,505 | $152.88 | 6.1% |
About Dr. David Dick, MD
Dr. David Dick, MD is a Cardiovascular Disease healthcare provider based in Tyler, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1477548618.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Dick, MD has received a total of $9,999 in payments from pharmaceutical and medical device companies, with $704.49 received in 2024. These payments were reported across 531 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($9,149).
As a Medicare-enrolled provider, Dick has provided services to 15,964 Medicare beneficiaries, totaling 21,270 services with total Medicare billing of $791,327. Data is available for 4 years (2020–2023), covering 115 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Tyler, TX
- Active Since 09/14/2005
- Last Updated 04/26/2017
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1477548618
Products in Payments
- Affinity Fusion (Device) $970.88
- XARELTO (Drug) $958.49
- Repatha (Biological) $954.21
- ENTRESTO (Drug) $811.59
- Corlanor (Drug) $614.60
- LifeVest (Device) $610.58
- LEQVIO (Drug) $558.16
- BRILINTA (Drug) $538.05
- ELIQUIS (Drug) $513.71
- Resolute (Device) $308.06
- Telescope (Device) $245.25
- ONYX FRONTIER (Device) $237.62
- TELESCOPE (Device) $185.26
- Reveal LINQ (Device) $183.85
- Barostim Neo System (Device) $183.39
- Xience Alpine cornary stent system (Device) $160.85
- Absorb GT1 (Device) $120.59
- RESOLUTE ONYX (Device) $115.51
- CHANTIX (Drug) $113.53
- Impella (Device) $112.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Tyler
Dr. John Sims, M.d, M.D
Cardiovascular Disease — Payments: $188,298
Cardiovascular Disease $188,298
Sherif Iskander, Md, MD
Cardiovascular Disease — Payments: $91,158
Cardiovascular Disease $91,158
Thaddeus Tolleson, Md, MD
Cardiovascular Disease — Payments: $53,717
Cardiovascular Disease $53,717
Dr. Jarett Berry, Md, MD
Cardiovascular Disease — Payments: $23,553
Cardiovascular Disease $23,553
Robert Smith, Md, MD
Cardiovascular Disease — Payments: $19,688
Cardiovascular Disease $19,688
Dr. Augustine Njoku, M.d, M.D
Cardiovascular Disease — Payments: $15,238
Cardiovascular Disease $15,238